Key result
Preoperative fasting serum glucose levels ≥126 mg/dL significantly increased the risk of postoperative mediastinitis in patients undergoing open heart surgery (OR, 5.25; P = .002).
Why the study?
Does elevated preoperative fasting serum glucose (≥ 126 mg/dL) increase the risk of postoperative mediastinitis in patients undergoing open heart surgery?
Does elevated preoperative fasting serum glucose (≥ 126 mg/dL) increase the risk of postoperative mediastinitis in patients undergoing open heart surgery?
Elevated preoperative fasting serum glucose (≥ 126 mg/dL) is a significant risk factor for developing postoperative mediastinitis following open heart surgery.
Alerts clinicians to preoperative glucose screening in open heart surgery; leaves open whether control reduces mediastinitis.
We conducted a case-control study to investigate the relationship between preoperative fasting serum glucose and postoperative mediastinitis in patients undergoing open heart surgery. Multivariate analysis revealed that a glucose level of 126 mg/dL or greater was associated with a significantly increased risk of mediastinitis (OR, 5.25; P = .002).
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2003) studied this question. Preoperative fasting serum glucose levels ≥126 mg/dL significantly increased the risk of postoperative mediastinitis in patients undergoing open heart surgery (OR, 5.25; P = .002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: